AGENTS TO ASSESS HEART ATTACK DAMAGE OK'dThe Food and Drug Administration approved two imagingagents, Du Pont Co.'s Cardiolite and Bristol-Myers Squibb'sCardiotec, that help assess the amount of undamaged heartmuscle following a heart attack. Both could compete withMyoscint, a radiolabeled monoclonal antibody made byCentocor Inc. of Malvern, Pa., which is approved for sale inEurope and is awaiting a review in the United States.
ONCOGENE GETS SBIR GRANT FOR IMMUNOASSAYS
Oncogene Science Inc. of Manhasset, N.Y., received a $500,000Phase II Small Business Innovation Research grant forimmunoassays that detect in the blood ras oncogene proteins,which are linked to many cancers.
(c) 1997 American Health Consultants. All rights reserved.